Sept 8 (Reuters) - SENSORION SA ALSEN.PA :
* SENSORION AND COCHLEAR TO BEGIN FIRST CLINICAL TRIAL OF
SENS-401
FOR HEARING PRESERVATION IN COMBINATION WITH COCHLEAR
IMPLANTATION
* STUDY WILL AIM TO MEASURE PERILYMPH PK OF SENS401 AND TO
EXPLORE
THERAPEUTIC EFFECT OF SENS-401 ON EARLY HEARING OUTCOMES UPON
COCHLEAR IMPLANTATION
* TRIAL WILL BE FULLY FUNDED UNDER EXISTING AGREEMENT
BETWEEN
COCHLEAR AND SENSORION
Source text for Eikon: ID:nBw7gRkdFa
Further company coverage: ALSEN.PA
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 587 696 600;))